MCMCB Pro
J1095

J1095Injection, dexamethasone 9 percent, intraocular, 1 microgram

HCPCSActiveBETOS O1E

J1095 is a HCPCS Level II code for injection, dexamethasone 9 percent, intraocular, 1 microgram. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Special coverage instructions apply

There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

Medically Unlikely Edits — units per day

The most units of J1095 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.

practitioner
1034 units
MAI 2 — Date of Service Edit: Policy · Anatomic Consideration
outpatient
1034 units
MAI 2 — Date of Service Edit: Policy · Anatomic Consideration

The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute — no documentation overrides it. CMS MUE 2026Q3.

The CMS record for J1095

Long descriptor
Injection, dexamethasone 9 percent, intraocular, 1 microgram

The official wording. This is what the code means.

Short descriptor
Injection, dexamethasone 9%

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2019

When CMS introduced the code.

BETOS
O1E

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
53 — Other

Statute.

Codes adjacent to J1095

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J1095 is not quite right, the correct code is very often within a few positions of it.

  • J1050Injection, medroxyprogesterone acetate, 1 mg
  • J1060Injection, testosterone cypionate and estradiol cypionate, up to 1 mlterminated
  • J1070Injection, testosterone cypionate, up to 100 mgterminated
  • J1071Injection, testosterone cypionate, 1 mg
  • J1072Injection, testosterone cypionate (azmiro), 1 mg
  • J1073Testosterone pellet, implant, 75 mg
  • J1080Injection, testosterone cypionate, 1 cc, 200 mgterminated
  • J1094Injection, dexamethasone acetate, 1 mgterminated
  • J1096Dexamethasone, lacrimal ophthalmic insert, 0.1 mg
  • J1097Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml
  • J1098Articaine ophthalmic, 8% solution, 0.4 ml
  • J1100Injection, dexamethasone sodium phosphate, 1 mg
  • J1105Dexmedetomidine, oral, 1 mcg
  • J1110Injection, dihydroergotamine mesylate, per 1 mg
  • J1120Injection, acetazolamide sodium, up to 500 mg
  • J1130Injection, diclofenac sodium, 0.5 mg

Questions about J1095

What is HCPCS code J1095?

J1095 is a HCPCS Level II code for injection, dexamethasone 9 percent, intraocular, 1 microgram. It sits in the Drugs Administered Other Than Oral Method section.

Does Medicare cover J1095?

The CMS HCPCS file marks J1095 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

How is J1095 paid under the physician fee schedule?

J1095 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

HCPCS Level II2026Q3-Jul· effective July 1, 2026